THE TREND IN THE ERADICATION RATES OF FIRST-LINE THERAPY FOR HELICOBACTER PYLORI INFECTION AND RISK FACTORS OF ERADICATION THERAPY

被引：0
|
作者：
Kim, S. [1 ]
Park, M. [1 ]
Park, S. [1 ]
Moon, W. [1 ]
Cheon, J. [1 ]
Kwon, H. [1 ]
Ku, K. [1 ]
Yoo, C. [1 ]
Kim, J. [1 ]
Lee, G. [1 ]
Song, S. [1 ]
Choi, Y. [1 ]
机构：
[1] Kosin Univ, Coll Med, Dept Internal Med, Pusan, South Korea
来源：
HELICOBACTER | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [31] Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    [J]. HELICOBACTER, 2016, 21 (05) : 382 - 388
  • [32] Risk factors for failure of Helicobacter pylori eradication therapy
    Broutet, N
    Tchamgoué, S
    Pereira, E
    Mégraud, F
    [J]. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 601 - 607
  • [33] Independent risk factors predicting eradication failure of standard bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection in Taiwan
    Shie, Chang-Bih
    Tsay, Feng-Woei
    Wu, Deng-Chyang
    Kao, Sung-Shuo
    Chen, Yan-Hua
    Tsai, Kun-Feng
    Huang, Wen-Wei
    Tang, Sheng-Yeh
    Kuo, Li-Fu
    Wu, I-Ting
    Hsu, Ping-, I
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2024,
  • [34] Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection
    Kim, Yeon-Ji
    Chung, Woo Chul
    Kim, Dae Bum
    [J]. HELICOBACTER, 2021, 26 (03)
  • [35] Efficacy of Moxifloxacin-Based Sequential Therapy and Hybrid Therapy as First-Line Eradication Regimen for Helicobacter pylori Infection
    Lee, Dong Ho
    Hwang, Jae Jin
    [J]. DIGESTION, 2017, 95 (01) : 94 - 95
  • [36] Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication
    Huang, Yao-Kang
    Wu, Meng-Chieh
    Wang, Sophie Sw
    Kuo, Chao-Hung
    Lee, Yi-Chern
    Chang, Ling-Li
    Wang, Tsung-Hsi
    Chen, Yen-Hsu
    Wang, Wen-Ming
    Wu, Deng-Chyang
    Kuo, Fu-Chen
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2012, 13 (04) : 232 - 238
  • [37] The Trend of Eradication Rates of First-Line Therapy and Second-Line Quadruple Therapy Containing Metronidazole for H. pylori Infection for Recent Five Years
    Park, J.
    Park, S.
    Kim, G.
    Seoul, S.
    Moon, J.
    Jee, S.
    Jung, H.
    Lee, D.
    Kim, J.
    Lee, S.
    [J]. HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [38] Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update
    Nyssen, Olga P.
    Martinez, Belen
    Megraud, Francis
    Savarino, Vincenzo
    Fallone, Carlo A.
    Bazzoli, Franco
    Gisbert, Javier P.
    [J]. ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [39] Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication
    Nista, Enrico C.
    Candelli, Marcello
    Zocco, Maria A.
    Cremonini, Filippo
    Ojetti, Veronica
    Finizio, Rosalba
    Spada, Cristiano
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : 1985 - 1990
  • [40] Comparing the Efficacy among Concomitant, Sequential, and Tailored Therapy as the First-Line Therapy for Helicobacter pylori Eradication
    Kim, Jin Il
    Cheung, Dae Young
    Kim, Jae J.
    Lee, Sang Woo
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S876 - S876
12345